Removal in Biological Technology

Lumenis(R) Introduces Cost-Saving Innovations at the 2009 American Academy of Dermatology (AAD) Annual Meeting

... advantages that enable affordable hair removal and fractional resurfacing despite challenging ... The LightSheer Duet reduces hair removal treatment times by up to 75% and vastly improves ... practitioner and patient acceptance of hair removal and fractional resurfacing, as well as increase ...

Cynosure Launches New Workstation and Technology Innovations at American Academy of Dermatology Annual Meeting

... Workstation Combines Vascular Treatment, Hair removal and Skin Rejuvenation in a Single System - ... workstations for vascular treatment, hair removal and skin rejuvenation. In addition, Cynosure is ... demand for hair removal, pigmented lesion removal and vascular ...

Palomar and Q-MED AB Terminate International Distribution Agreement

... treatments. Palomar pioneered the optical hair removal field, when, in 1997, it introduced the first high-powered laser hair removal system. Since then, many of the major advances in light-based hair removal have been based on Palomar technology. In ...

Intact Medical Corporation's Intact(R) Excise XL Receives 510(K) Marketing Clearance from the FDA

... minimally invasive systems for the diagnosis and removal of breast lesions, today announced that it has ... histologic examination with partial or complete removal of an imaged abnormality, or partial removal of a palpable abnormality that has ...

Bion Announces Approval of New U.S. Patent for Phosphorus Removal Process for Livestock Waste Environmental Treatment

... until December 26, 2021. Bion's new phosphorus removal patent coverage broadens and deepens ... waste, through simultaneous removal and stabilization of nutrients and reduction of ... worldwide. Bion's technology employs a nutrient removal process driven by the system's active biology ...

ProMetic Further Confirms Performance of Prion Capture Resin at the Recovery of Biological Products Conference

... of the prion capture resins developed by Pathogen removal and Diagnostic Technologies Inc. ("PRDT")' in the removal of prions from different solutions, including ... . About Pathogen removal and Diagnostic Technologies Inc. ...

Quest PharmaTech Announces Interim Results from Phase I/II Clinical Trial for Photodynamic Treatment for Hair Removal

... use of its proprietary compound SL017 for hair removal applications. The interim results represent ... trial, support the utility of SL017 for hair removal applications, especially for those who do not ... patient population. The professional laser hair removal market is estimated to be $5 billion worldwide. ...

ProMetic announces Octapharma publication of PRDT'S prion removal resin in Octaplas(R) manufacturing process at 30th International Congress of the International Society for Blood Transfusion meeting in Macao SAR, China

... Symposium at meeting to discuss prion removal capacity, technical performance and product ... presenting data on the utility of Pathogen removal and Diagnostics Technologies Inc.'s ("PRDT") prion removal resin technology in this application. The use ...

ProMetic to obtain controlling stake in Pathogen Removal and Diagnostic Technologies Inc.

... Cross' ("ARC") common stock holding in Pathogen removal and Diagnostic Technologies Inc. ("PRDT"), the ... the American National Red Cross. About Pathogen removal and Diagnostic Technologies Inc. Pathogen removal and Diagnostic Technologies Inc. ("PRDT") is a ...

TRIA At-Home Laser Hair Removal Device Cleared by FDA

... (FDA) for their patented hand-held laser hair removal device designed for at-home use. The TRIA is the first hair removal laser to enter the U.S. home-based device market, ... "I have been performing laser hair removal in my office for 12 years and welcome the arrival ...

ProMetic announces scale-up of prion removal resin in plasma product for biopharmaceutical use

... dollar long-term agreement to supply prion removal affinity resin following regulatory approval ... first phases of development utilizing Pathogen removal and Diagnostic Technologies Inc.'s ("PRDT") ligand technology for prion binding and removal from a plasma product for biopharmaceutical use ...

Palomar and Q-MED AB Enter Into International Distribution Agreement

... treatments. Palomar pioneered the optical hair removal field, when, in 1997, it introduced the first high-powered laser hair removal system. Since then, many of the major advances in light-based hair removal have been based on Palomar technology. In ...

Bion Announces Approval of New U.S. Patent that Broadens Protection for the Company's Livestock Waste Environmental Treatment Processes

... Bion's Chief Technology Officer, stated, "This new patent describes the removal of phosphorus utilizing a new and unique process and system configuration. ... solution to concentrated livestock waste, through simultaneous removal and stabilization of nutrients and reduction of air emissions including ...

Dendreon Announces Data on PROVENGE Potency and Long-Term Immune Responses in Androgen-Dependent Prostate Cancer

... have had a prostate-specific antigen (PSA) recurrence following surgical removal of the prostate. Patients were randomized to PROVENGE or placebo following ... have had a prostate-specific antigen (PSA) recurrence following surgical removal of the prostate. A total of 176 patients at 19 sites in the United States ...

HybridSPE(TM)-Precipitation Technology Wins SelectScience.net 2009 Scientists' Choice Award for Best New Separations Product in 2008

... of protein precipitation with the selectivity of SPE for the targeted removal of phospholipids and proteins from biological samples prior to LC-MS/MS ... and generic sample preparation platform designed for the gross level removal of endogenous protein and phospholipid interferences from biological ...

TechniKrom's Biopharmaceutical Equipment Operations to be Integrated With Asahi Kasei Medical

... in the commercialization of equipment for use with Planova(TM) virus removal filters, have reached agreement for the transfer of TechniKrom's ... field is centered on Planova(TM) filters and filtration systems for virus removal in the production of biopharmaceuticals. "The product line synergies with ...

Coalition for the Advancement of Medical Research Releases New White Paper, 'Catalyst for Cures: Embryonic Stem Cell Research'

... stem cell researchers -- in academia and industry -- make clear that, with removal of limits on Federal funding, embryonic stem cell research will fulfill ... cancer, spinal cord injuries, and heart disease. The time for removal of restrictions, expanded support, and implementation of relevant ...

Sigma-Aldrich Acquires Seppro(R) Depletion Technology From GenWay Biotech

... and rat samples, as well as the industry's only depletion system for the removal of Rubisco. The library of 700 polyclonal IgY antibodies acquired ... collection of depletion products, including ProteoPrep(R) kits for the removal of highly abundant proteins, such as albumin and IgG, from human serum and ...

Omeros Announces Results from a Phase 1 Study of OMS201 for Use During Urological Surgery

... The Phase 1 study of OMS201 enrolled patients undergoing endoscopic removal of urinary stones, and was designed to evaluate the systemic absorption ... and safety of OMS201 in patients receiving primary treatment by endoscopic removal of urinary stones. OMS201, developed from Omeros' proprietary ...

Genomma Lab Reaffirms Zero Ownership Stake in the Laser Hair Removal Chains Neoskin and Depilite

... products company announced today that it owns no shares in the laser hair removal chain "Neoskin," which has recently been the subject of negative news ... and reiterates that it has no plans to participate in the laser hair removal business in the future. The Company continues with its current business ...

Trinity Biotech Management Refuses to Honor Call for a Special Meeting of Shareholders

... refusing to a request for a special shareholders meeting to consider the removal and replacement of its current directors, management of Trinity Biotech ... of a special meeting of Trinity Biotech shareholders to consider the removal of the current Trinity Biotech directors and their replacement by a slate ...

Misonix Announces New Distribution Agreement for The Netherlands

... The SonaStar is used by Neuro and General Surgeons for quick and efficient removal of both hard and soft tumors while sparing most vessels. In addition, ... system that offers tissue specific debridement and cleansing for effective removal of devitalized tissue and fibrin deposits while sparing viable ...

Advanced Pest Control Earns Quality Pro Designation for General Pest Control Services

... Advanced Pest Control, the Houston based pest control and animal removal company, is happy to announce their recent Quality Pro designation, a mark ... 2008 -- Advanced Pest Control, the Houston based pest control and animal removal company, is happy to announce their recent Quality Pro designation for ...

Chest Physicians Now Suggest Early Intervention for Certain Blood Clots in DVT

... a major advance in treatment. Adopting an initial strategy of thrombus removal will improve the quality of life of these patients and potentially avoid ... surgeon, founded the company with the vision of transforming blood clot removal from peripheral blood vessels into a fast, simple, minimally-invasive ...

'Nanosculpture' could enable new types of heat pumps and energy converters

... "First, the core-shell junctions in the nanorods are conducive for heat removal upon application of an electrical voltage, or generating electrical power ... open up the possibility of fabricating miniaturized conduits for heat removal alongside nanowire interconnects in future device architectures." The ...

Cynosure Reports 41% Revenue Increase: 10th Consecutive Quarter of Revenue Growth

... as our flagship solutions for laser lipolysis, anti-aging and hair removal all posted double-digit percentage revenue gains," said Cynosure President ... is a high-powered 755-nm, Q-switched Alexandrite laser for the removal of benign pigmented lesions, including Nevus of Ota and Nevus of Ito, ...

Prometic to present at the American Chemical Society

... related industries, including ProMetic Life Sciences Inc. About Pathogen removal and Diagnostic Technologies Inc. Pathogen removal and Diagnostic Technologies Inc. ("PRDT") is a joint venture established ...

Schering-Plough and OraSure Technologies Sign International Collaboration for Rapid Point-of-Care Oral Hepatitis C Test

... entities. In addition, OraSure sells products for the cryosurgical removal of common and plantar warts in the over-the-counter or retail market in ... countries, Australia and New Zealand, and a product for the cryosurgical removal of common and plantar warts and several other benign skin lesions to the ...

ProMetic provides business update - Over $35 million worth of business secured in January

... decision of a major European plasma fractionator to scale-up the prion removal process. This process ensures the removal of any abnormal prion proteins that may be present in donated plasma ...

ProMetic and MacoPharma announce successful completion of P-Capt(R) prion reduction filter clinical studies

... in the US, Europe, Asia and in the Middle-East. About Pathogen removal and Diagnostic Technologies Inc. Pathogen removal and Diagnostic Technologies Inc. ("PRDT") is a joint venture established ...

Quest PharmaTech to Receive $3,000,000 to Develop Oncology Products Based on its SonoLight Technology

... is currently undergoing a 90 patient clinical trial in Canada for hair removal applications. Quest has signed an exclusive multinational license ... Co. Ltd, a Korean pharmaceutical company, to market SL017 in Asia for hair removal applications. Except for historical information, this press release may ...

Report recommends off-site disposal of secondary waste

... this waste is nonhazardous and can be easily disposed of through removal to an off-site facility. If exposed to a contaminant, the dunnage can be ... solutions are used to wash work areas and decontaminate workers prior to removal of their suits. They are analyzed for contaminants, treated if necessary, ...

Report recommends off-site disposal of secondary waste

... this waste is nonhazardous and can be easily disposed of through removal to an off-site facility. If exposed to a contaminant, the dunnage can be ... solutions are used to wash work areas and decontaminate workers prior to removal of their suits. They are analyzed for contaminants, treated if necessary, ...

Angiotech Pharmaceuticals, Inc. announces financial results for the second quarter ended June 30, 2009

... subsequent pulmonary embolism, significant filter migration or embolization, symptomatic caval thrombosis or other complications requiring filter removal or invasive intervention. The Option IVC Filter was licensed in March 2008 from our partner Rex Medical L.P. ("Rex Medical"). We are obligated to ...

New Pre-Clinical Data on OmniGuide's BeamPath NEURO(TM) Demonstrates Precise Cutting in Brain Tissue

... to precisely and hemostatically cut in the brain while minimizing loss of precious brain tissue has a real potential for improving brain tumor removal efficacy," said Yoel Fink, president and CEO of OmniGuide. "Since the launch of the BeamPath NEURO, we've seen strong demand for our technology and ...

Angiotech Pharmaceuticals announces FDA 510(k) clearance of the Option(TM) Inferior Vena Cava Filter

... technical success without subsequent PE, significant filter migration or embolization, symptomatic thrombosis or other complications requiring filter removal or intervention, was achieved in 88% of subjects. Retrieval success was achieved in 92% (36/39) of cases where retrieval was attempted, with a mean ...

Intarcia Therapeutics, Inc. Presents ITCA 650 Phase 1b Study Results as a Late-Breaker at the American Diabetes Association 69th Scientific Sessions

... ITCA 650 therapy in this phase 1b trial was administered for the full course of treatment with a single insertion of the ITCA 650 on day 1 and removal on day 29. The phase 2 trial will evaluate ITCA 650 against the current standard of care for a longer duration of treatment and among a larger ...

Intarcia Therapeutics, Inc. Announces Acceptance of ITCA 650 Phase 1b Study for Late-Breaker Presentation at the American Diabetes Association 69th Scientific Sessions

... ITCA 650 therapy in this phase 1 trial is administered for the full course of therapy with a single insertion of the DUROS device on day 1 and removal on day 29. Results of the phase 1 study have supported the selection of doses to be evaluated in a controlled phase 2 study planned to begin later ...

Research Reinforces Economic, Environmental Benefits of Corn Cobs as Source for Cellulosic Ethanol

... plant. The collaboration between POET and ISU takes a closer look at data regarding soil quality and nutrient levels, the impact of cob and stover removal on future plant growth and recommended levels of fertilizer applications, if any, for cob or stover removal. In addition, POET is investigating the ...

Dendreon Reports First Quarter 2009 Financial Results

... non-metastatic androgen-dependent (hormone sensitive) prostate cancer who have had a prostate-specific antigen (PSA) recurrence following surgical removal of the prostate. "The significant increase in overall survival demonstrated in our Phase 3 IMPACT trial for PROVENGE is a ...